Donna Gill
Psychiatry · Zionsville, INNPI 1316101363
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 256 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,647, 2.5 times the $669 reported in 2019.
Across 256 payments — averaging $16.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$612
- Otsuka America Pharmaceutical, Inc.$462
- Tris Pharma Inc$399
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$393
- Neurocrine Biosciences, Inc.$309
- Corium, LLC$286
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,122100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 23 | $612 |
| Otsuka America Pharmaceutical, Inc. | 25 | $462 |
| Tris Pharma Inc | 42 | $399 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $393 |
| Neurocrine Biosciences, Inc. | 18 | $309 |
| Corium, LLC | 23 | $286 |
| AbbVie(2 entities) | 12 | $219 |
| Supernus Pharmaceuticals, Inc. | 9 | $216 |
| Lundbeck LLC | 11 | $185 |
| Teva Pharmaceuticals USA, Inc. | 10 | $169 |
| Alkermes, Inc. | 9 | $147 |
| Collegium Pharmaceutical, Inc. | 10 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $88 |
| Ironshore Pharmaceuticals Inc. | 5 | $83 |
| Sunovion Pharmaceuticals Inc. | 7 | $71 |
| Johnson & Johnson | 4 | $66 |
| Neos Therapeutics, LP | 3 | $59 |
| E.r. Squibb & Sons, L.L.C. | 3 | $59 |
| Vertical Pharmaceuticals, LLC | 2 | $33 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Noven Therapeutics, LLC | 1 | $23 |
| Luye Pharma (USA) Ltd. | 1 | $21 |
| Rhodes Pharmaceuticals L.p. | 1 | $19 |
| Indivior Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| OWP Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,134 in reported general payments places this provider in the 85th percentile of 514 psychiatry providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Guanfacine Hcl ErGuanfacine Hcl | 14 | $271 |
| Quetiapine Fumarate | 16 | $240 |
| Buspirone Hcl | 16 | $176 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $145 |
| Clonazepam | 23 | $136 |
| Trazodone Hcl | 21 | $26 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Zionsville
- Steven PaulCarmel$2.9M
- Jay FawverAngola$1.4M
- Suhayl NasrMichigan City$739K
- Christopher BojrabCarmel$713K
- Joseph FanelliMunster$443K
- Eric JaggersJeffersonville$260K
- Larry LambertsonFort Wayne$208K
- Louis CadyNewburgh$135K
- Charles BeasleyIndianapolis$129K
- Muhammad MunirAnderson$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.